OSE Pharma Financials
| OSE Stock | EUR 8.89 0.21 2.42% |
OSE |
Understanding current and past OSE Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of OSE Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in OSE Pharma's assets may result in an increase in income on the income statement.
Please note, the presentation of OSE Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OSE Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of OSE Pharma's management manipulating its earnings.
OSE Pharma Stock Summary
OSE Pharma competes with Biomerieux, Eurofins Scientific, Sartorius Stedim, and SEB SA. OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.| Foreign Associate | USA |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0012127173 |
| Business Address | 22, boulevard Benoni |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ose-immuno.com |
| Phone | 33 2 28 29 10 10 |
| Currency | EUR - Euro |
You should never invest in OSE Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of OSE Stock, because this is throwing your money away. Analyzing the key information contained in OSE Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
OSE Pharma Key Financial Ratios
OSE Pharma's financial ratios allow both analysts and investors to convert raw data from OSE Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of OSE Pharma over time and compare it to other companies across industries.| Return On Equity | -0.15 | |||
| Return On Asset | -0.0528 | |||
| Target Price | 14.1 | |||
| Number Of Employees | 60 | |||
| Beta | 1.06 |
OSE Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OSE Pharma's current stock value. Our valuation model uses many indicators to compare OSE Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OSE Pharma competition to find correlations between indicators driving OSE Pharma's intrinsic value. More Info.OSE Pharma SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OSE Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OSE Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.OSE Pharma SA Systematic Risk
OSE Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OSE Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on OSE Pharma SA correlated with the market. If Beta is less than 0 OSE Pharma generally moves in the opposite direction as compared to the market. If OSE Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OSE Pharma SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OSE Pharma is generally in the same direction as the market. If Beta > 1 OSE Pharma moves generally in the same direction as, but more than the movement of the benchmark.
OSE Pharma November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OSE Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OSE Pharma SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of OSE Pharma SA based on widely used predictive technical indicators. In general, we focus on analyzing OSE Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OSE Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.04 | |||
| Information Ratio | 0.0708 | |||
| Maximum Drawdown | 25.35 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 7.17 |
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |